SQ-LIP-000001 · v1.1 (archived) · View current version →
Is lipedema a distinct disease, separate from obesity and lymphedema?
Based on currently indexed evidence, lipedema is treated as a distinct clinical entity separate from obesity and lymphedema. Recent studies indicate that patients with lipedema exhibit distinct imaging characteristics compared to those with lipolymphedema, further supporting the notion of lipedema as a separate condition. Additionally, it is suggested that lipedema is hormonally influenced, reinforcing its classification as distinct from obesity. However, it is important to note that all three conditions can coexist, and no objective gold-standard diagnostic test exists; the distinction relies on clinical criteria and expert consensus.
Knowledge freshness = share of the 9 indexed evidence sources from the last 5 years (newest 2026, oldest 2019) . Low freshness flags an ageing evidence base — not that the answer is wrong.
Evidence over time
supporting contradicting refining / context Each dot is a study, placed by year and coloured by whether the linked claim supports or contradicts the answer. As the surveillance loop runs, claim revisions and new evidence will extend this timeline.
Choose a format (Vancouver default). Citing a version captures the evidence state on that date; this page shows the current version — see version history.
What changed in this version
This update added evidence suggesting distinct imaging characteristics in lipedema compared to lipolymphedema and a hormonal influence on lipedema, reinforcing its classification as a separate condition.
Supporting claims
- SCR-LIP-000001 supporting
Lipedema is a distinct clinical entity separate from obesity and lymphedema, characterized by bilateral, symmetrical, painful subcutaneous fat accumulation of the lower limbs that spares the feet, although all three can coexist.
DOI:10.1590/1677-5449.202301832 · Amato ACM, 2020 · DOI:10.1016/j.mri.2020.06.010 · DOI:10.1007/s00404-026-08318-1 - SCR-LIP-000044 supporting
Lipedema is defined by a disproportionate, symmetrical accumulation of subcutaneous adipose tissue in the limbs relative to the trunk that is characteristically resistant to conventional weight-loss methods (diet and exercise), distinguishing it from common obesity.
DOI:10.1590/1677-5449.202301832 - SCR-LIP-000003 supporting
In the Brazilian Delphi consensus, experts agreed that lipedema and obesity do not have a causal relationship and that BMI is of limited value in differentiating lipedema from obesity.
DOI:10.1590/1677-5449.202301832
Contradictory claims
- None indexed yet.
Refining / context
- SCR-LIP-000002 context
Clinical signs that help diagnose lipedema and distinguish it from lymphedema include a usually negative Kaposi-Stemmer sign, the cuff sign with foot sparing, fat painful on palpation, easy bruising, and minimal pitting edema (Stemmer becomes positive only when secondary lymphedema/lipolymphedema develops).
DOI:10.1590/1677-5449.202301832 · Amato ACM, 2019 - SCR-LIP-000045 context
Patients with lipedema frequently report swelling and a sensation of heaviness in the affected limbs.
DOI:10.1590/1677-5449.202301832
Major uncertainty
The lack of a gold-standard diagnostic test means that the distinction between lipedema, obesity, and lymphedema relies heavily on clinical criteria and expert consensus, which may vary.
Version history
- SQ-LIP-000001 · v1.1 — 2026-05-30 — This update added evidence suggesting distinct imaging characteristics in lipedema compared to lipolymphedema and a hormonal influence on lipedema, reinforcing its classification as a separate condition. · view this version
- SQ-LIP-000001 · v1.0 — 2026-05-30 — founding index (5 claims) · view this version
Key references
DOI:10.1590/1677-5449.202301832 · DOI:10.1016/j.mri.2020.06.010 · DOI:10.1007/s00404-026-08318-1